A Phase I, Randomised, Double-Blind, Placebo-Controlled, Dose-Escalating Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Intravenous CT-P27 in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 31 May 2017
At a glance
- Drugs CT P27 (Primary)
- Indications Influenza virus infections
- Focus Adverse reactions; First in man
- 07 Sep 2016 New trial record